We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

61 hedge funds and large institutions have $88.7M invested in Genocea Biosciences, Inc. in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 6

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

24% more funds holding

Funds holding: 49 → 61 (+12)

6% less capital invested

Capital invested by funds: $94M → $88.7M (-$5.32M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

99% less call options, than puts

Call options by funds: $1K | Put options by funds: $69K

Holders
61
Holders Change
+12
Holders Change %
+24.49%
% of All Funds
1.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
22
Increased
18
Reduced
6
Closed
10
Calls
$1K
Puts
$69K
Net Calls
-$68K
Net Calls Change
-$184K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.89M
2
State Street
State Street
Massachusetts
+$2.07M
3
Northern Trust
Northern Trust
Illinois
+$1.6M
4
NC
Northpointe Capital
Michigan
+$706K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$631K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$2.92M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.36M
3
SFM
Sphera Funds Management
Israel
-$940K
4
Millennium Management
Millennium Management
New York
-$321K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$271K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$22.3M +$5.49K +114 +0%
Franklin Resources
2
Franklin Resources
California
$15.6M – – –
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$10.3M – – –
BlackRock
4
BlackRock
New York
$7.49M +$6.89M +143,126 +397%
NC
5
Northpointe Capital
Michigan
$6.97M +$706K +14,672 +10%
Vanguard Group
6
Vanguard Group
Pennsylvania
$4.47M +$631K +13,098 +14%
Axa
7
Axa
France
$3.06M -$132K -2,734 -4%
SFM
8
Sphera Funds Management
Israel
$2.56M -$940K -19,534 -24%
RSCM
9
Rock Springs Capital Management
Maryland
$2.51M – – –
State Street
10
State Street
Massachusetts
$1.91M +$2.07M +43,072 +1,595%
Northern Trust
11
Northern Trust
Illinois
$1.6M +$1.6M +33,166 +643%
AA
12
AlphaMark Advisors
Kentucky
$1.59M – – –
Principal Financial Group
13
Principal Financial Group
Iowa
$1.14M – – –
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.01M +$271K +5,622 +30%
BCM
15
Bridgeway Capital Management
Texas
$788K – – –
WA
16
Wasatch Advisors
Utah
$517K – – –
Bank of New York Mellon
17
Bank of New York Mellon
New York
$439K +$433K +9,001 +595%
TCIM
18
TIAA CREF Investment Management
New York
$404K +$466K +9,685 New
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$313K – – –
TA
20
Teachers Advisors
New York
$268K +$309K +6,413 New
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$265K +$305K +6,338 New
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$262K -$6.64K -138 -2%
Charles Schwab
23
Charles Schwab
California
$257K +$296K +6,138 New
Morgan Stanley
24
Morgan Stanley
New York
$211K +$145K +3,015 +148%
BC
25
Birchview Capital
Vermont
$204K – – –
1
2 3

GNCA Hedge Fund Activity: Q2 2017 in Review

61 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q2 2017, worth a combined $88.7M — down 5.7% from $94M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new GNCA positions and 10 closed out — a net gain of 12 holders — while 18 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock, adding an estimated $6.89M. The largest seller was Deerfield Management, exiting entirely with an estimated $2.92M sold.

  • 61 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q2 2017, up from 49 in Q1 2017.
  • Funds reported $88.7M of Genocea Biosciences, Inc. stock for Q2 2017, down 5.7% quarter-over-quarter.
  • 22 funds opened new Genocea Biosciences, Inc. positions in Q2 2017 and 10 closed out, a net change of +12 holders.
  • The largest Genocea Biosciences, Inc. buyer in Q2 2017 was BlackRock, an estimated $6.89M added.
  • The largest Genocea Biosciences, Inc. seller in Q2 2017 was Deerfield Management, an estimated $2.92M sold.

Based on aggregated 13F filings for Q2 2017.